Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (261-270 of 368) with videos related to

Pageof 37
Sort By:
Advances in Radiation Oncology|July 26, 2017
18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaRyan S Youland, Ann T Packard, Miran J Blanchard, et al.
Cancer Research Communications|August 22, 2022
Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockadeRachel L G Maus, Alexey L Leontovich, Raymond M Moore, et al.
Transplantation and Cellular Therapy|June 6, 2021
Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control StudyLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Leukemia|November 11, 2005
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemiaD Behl, L F Porrata, S N Markovic, et al.
Cancer|August 14, 2020
Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysisItunu Owoyemi, Lisa E Vaughan, Collin M Costello, et al.
Melanoma Research|August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital settingRonen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Neurology|August 16, 2020
Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomesElia Sechi, Svetomir N Markovic, Andrew McKeon, et al.
Molecular & Cellular Proteomics : MCP|November 21, 2025
Proteomic Analysis of Small Extracellular Vesicles From Lymphatic Affluents in Developing Premetastatic Niche in MelanomaShankar Suman, Liyi Geng, Wendy K Nevala, et al.
Blood|January 5, 2002
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphomaStephen M Ansell, Thomas E Witzig, Paul J Kurtin, et al.
Breast Cancer Research : BCR|March 13, 2012
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expressionMohan Liu, Liewei Wang, Tim Bongartz, et al.
Pageof 37

Showing results (261-270 of 368) with videos related to

Sort By:
Pageof 37
Advances in Radiation Oncology|July 26, 2017
18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaRyan S Youland, Ann T Packard, Miran J Blanchard, et al.
Cancer Research Communications|August 22, 2022
Resolving the heterogeneous tumor-centric cellular neighborhood through multiplexed, spatial paracrine interactions in the setting of immune checkpoint blockadeRachel L G Maus, Alexey L Leontovich, Raymond M Moore, et al.
Transplantation and Cellular Therapy|June 6, 2021
Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control StudyLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Leukemia|November 11, 2005
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemiaD Behl, L F Porrata, S N Markovic, et al.
Cancer|August 14, 2020
Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysisItunu Owoyemi, Lisa E Vaughan, Collin M Costello, et al.
Melanoma Research|August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital settingRonen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.
Neurology|August 16, 2020
Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomesElia Sechi, Svetomir N Markovic, Andrew McKeon, et al.
Molecular & Cellular Proteomics : MCP|November 21, 2025
Proteomic Analysis of Small Extracellular Vesicles From Lymphatic Affluents in Developing Premetastatic Niche in MelanomaShankar Suman, Liyi Geng, Wendy K Nevala, et al.
Blood|January 5, 2002
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphomaStephen M Ansell, Thomas E Witzig, Paul J Kurtin, et al.
Breast Cancer Research : BCR|March 13, 2012
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expressionMohan Liu, Liewei Wang, Tim Bongartz, et al.
Pageof 37